Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655081 · ClinicalTrials.gov registry record · Phase 2
Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT02655081: Completed Phase 2 study, sponsored by University of Pittsburgh.
NCT02655081 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 48 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02655081, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
To provide patients with bladder cancer who are scheduled to undergo radical cystectomy with a preoperative high-arginine nutritional supplement. The investigator will measure patient adherence to the regimen, tolerability of the supplement and feasibility of supplementation. Secondary outcome measures will include differences in length of stay and complication rate between groups.
Primary Outcome
Investigator will report on any adverse events from supplementation as well as patient adherence to regimen.
Interventions
- DIETARY_SUPPLEMENT high arginine nutritional supplement (Nestle's Impact AR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
What the finished NCT02655081 record still lists
NCT02655081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which high arginine nutritional supplement (Nestle's Impact AR) is the first listed.
NCT02655081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02655081 about?
NCT02655081 is a clinical study titled "Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy". To provide patients with bladder cancer who are scheduled to undergo radical cystectomy with a preoperative high-arginine nutritional supplement. The investigator will measure patient adherence to the regimen, tolerability of the supplement and feasibility of supplementation. Secondary outcome measu...
What is the current status of trial NCT02655081?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2015-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02655081?
The interventions under investigation include: high arginine nutritional supplement (Nestle's Impact AR) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02655081?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02655081's enrollment target sits among peer trials
48 1265th of 2000 higher than 718 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia